Trial NCT00768989

View at ClinicalTrials.gov 
Org. Study IDs: AI424-376

Last trial update was posted on 2012-02-24

MeSH Interventions

Atazanavir Sulfate Emtricitabine Raltegravir Potassium Ritonavir Tenofovir

MeSH Conditions


Other Conditions

HIV

Stopping Reasons

Efficacy endpoint met, but overall experimental dosing regimen not considered optimal to support further clinical development in this population.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID